G. Pohl-Boskamp GmbH & Co. KG   Report issue

For profit Phase 2
Founded: Hohenlockstedt Germany (1991)
Status: No NME R&D (1991)

Organization Overview

First Clinical Trial
2013
NCT01914627
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

dimeticone (1 trial)

salicylic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2